EPA approves BASF's Aseptrol S10 - Tab for H1N1 sanitization operations

NewsGuard 100/100 Score

BASF today announced that the Environmental Protection Agency (EPA) has approved the use of Aseptrol® S10 - Tab in H1N1 sanitization operations in institutional and industrial facilities, such as, schools, hospitals, government buildings, retail and restaurants, and recreational facilities. Aseptrol S10 - Tab is based on Chlorine dioxide (CIO2) release technology.

"Aseptrol S10 - Tab delivers a broad spectrum disinfectant as stated in the EPA label and kills a large number of pathogens, such as H1N1 virus, Avian Influenza A (H3N2), Influenza A, and HIV, on contact surfaces," said Gary Dee, Business Director, Home and Personal Care, Care Chemicals North America at BASF. "The tablet is stable when dry and is packed in foil pouches, saving energy and reducing overall logistics costs."

High efficiency CIO2 is formed in the pores of the tablet when immersed in water. As the tablet dissolves, this powerful oxidizer disperses into the bulk solution. Using the Aseptrol S10 - Tab is as easy as Drop, Spray and Wipe: Drop the tablet in a spray bottle containing water, spray it evenly on a non-porous surface and wipe the surface until dry. Treated surfaces must remain wet for 10 minutes (or 30 minutes for Foot and Mouth Disease Virus). The solution does not leave a residue.

SOURCE BASF Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough in gene editing: Enhanced virus-like particles promise new era in genetic disease treatment